We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-18.08%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$60.2M
AUM Growth
-$115M
Cap. Flow
-$94.3M
Cap. Flow %
-156.58%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$94.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIGL
1
DELISTED
Vigil Neuroscience
VIGL
$39.6M 65.75%
4,214,498
– –
TBIO
2
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$15.6M 25.82%
546,896
– –
CELL
3
DELISTED
PhenomeX Inc. Common Stock
CELL
$2.64M 4.38%
5,390,820
– –
CADL icon
4
Candel Therapeutics
CADL
$689M
$2.44M 4.05%
1,935,215
– –
DICE
5
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-3,292,871
Closed -$94.3M

Similar funds

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Northpond Ventures's Q2 2023 Portfolio in Review

As of Q2 2023, Northpond Ventures held 5 positions worth $60.2M, down 66% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Northpond Ventures withdrew a net $94.3M in Q2 2023, closing 1 position. Its most notable exit was DICE Therapeutics, Inc. Common Stock, an estimated $94.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures fully exited DICE Therapeutics, Inc. Common Stock in Q2 2023, selling an estimated $94.3M.
  • Northpond Ventures's ten largest holdings make up 100% of its $60.2M portfolio in Q2 2023.
  • Northpond Ventures opened 0 new positions and closed 1 in Q2 2023.
  • Northpond Ventures's portfolio value fell 66% quarter-over-quarter to $60.2M.

Based on Northpond Ventures's 13F filing for Q2 2023, filed 14 Aug 2023.